Pathogenesis of Thromboembolism and Endovascular Management
Thrombosis · 05.01.2017 · 2017 · 1-13
DOI: 10.1155/2017/3039713 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Thrombosis, erschienen am 05.01.2017. Verfasst von Sasan Behravesh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular & Interventional Radiology, Mayo Clinic Arizona, 5777 E Mayo Blvd, Phoenix, AZ 85054, USA; Department of Radiology, Mayo Clinic …. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Venous thromboembolism (VTE), a disease that includes deep venous thrombosis (DVT) and pulmonary embolism (PE), is associated with high mortality, morbidity, and costs. It can result in long-term complications that include postthrombotic syndrome (PTS) adding to its morbidity. VTE affects 1/1000 patients, costs $13.5 billion annually to treat, and claims 100,000 lives annually in the US. The current standard of care for VTE is anticoagulation, though thrombolysis may be performed in patients with PE and threatened limb. This review discusses pathogenesis and medical treatment of VTE and then focuses on endovascular treatment modalities. Mechanical- and catheter-directed thrombolysis (CDT) is discussed, as well as patient selection criteria, and complications. The first prospective study (CaVenT) comparing CDT with anticoagulation alone in acute DVT, despite study shortcomings, corroborates the existing literature indicating improved outcomes with CDT. The potential of the ongoing prospective, multicenter, randomized ATTRACT trial is also highlighted.
Autor:innen und Institutionen
- Division of Vascular & Interventional Radiology, Mayo Clinic Arizona, 5777 E Mayo Blvd, Phoenix, AZ 85054, USA; Department of Radiology, Mayo Clinic Arizona, 5777 E Mayo Blvd, Phoenix, AZ 85054, USA.
- Department of Interventional Radiology, Division of Diagnostic Imaging, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
- Division of Interventional Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
- Center of Nanotechnology, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
ORCID-Profile: Rahmi Oklu
Zitieren
APA
Behravesh, S., Hoang, P., Nanda, A., Wallace, A., Sheth, R. A., Deipolyi, A. R., Memic, A., Naidu, S., & Oklu, R. (2017). Pathogenesis of Thromboembolism and Endovascular Management. Thrombosis, 2017, 1-13. https://doi.org/10.1155/2017/3039713
Vancouver
Behravesh S, Hoang P, Nanda A, Wallace A, Sheth RA, Deipolyi AR, et al. Pathogenesis of Thromboembolism and Endovascular Management. Thrombosis. 2017;2017:1-13. doi:10.1155/2017/3039713
BibTeX
@article{Behravesh2017,
author = {Behravesh, Sasan and Hoang, Peter and Nanda, Alisha and Wallace, Alex and Sheth, Rahul A and Deipolyi, Amy R and Memic, Adnan and Naidu, Sailendra and Oklu, Rahmi},
title = {Pathogenesis of Thromboembolism and Endovascular Management},
journal = {Thrombosis},
year = {2017},
volume = {2017},
pages = {1--13},
doi = {10.1155/2017/3039713}
}
EUVIMED